01271nam 2200397 450 00000328420070503173300.0--------d1953----km-y0itay0103----baengUSJezebel's husban<<The>> sleeping beautyRobert Nathan1 0003470New YorkKnopf1953209 p.20 cm.812.5Nathan,Robert439136ITUniversità della Basilicata - B.I.A.RICAunimarc000003284Jezebel's husban72741UNIBASMONLETMONOGRLETTERESTOLFI0119991011BAS011637STOLFI0119991012BAS01153920000913BAS01142520000920BAS01183120001010BAS01163320050601BAS011753batch0120050718BAS01104720050718BAS01110720050718BAS01113720050718BAS011151BATCH0020070503BAS011733BAS01BAS01BOOKBASA1Polo Storico-UmanisticoGENCollezione generaleFP/4015FP/40154015L40151999101102Prestabile Generale04144nam 2201069z- 450 991055729110332120210501(CKB)5400000000041128(oapen)https://directory.doabooks.org/handle/20.500.12854/69153(oapen)doab69153(oapen)69153(EXLCZ)99540000000004112820202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierMycobacterium tuberculosis Pathogenesis, Infection Prevention and TreatmentBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (128 p.)3-03936-658-0 3-03936-659-9 Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment" that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.Biology, life sciencesbicsscResearch & information: generalbicsscResearch and information: generalbicsscantitubercular drug discoveryantitubercular treatmentsapoptosisBeijing B0/W148Beijing genotypeBM-MSCsbone-homingCD38Central Asia Outbreakcytokinedrug discoverydrug resistancedrug targeteffectoreffluxgene expressionHLA-DRhost-pathogen interactionsIL-18IL-18BPIL-18Rimidazo[1,2-b][1,2,4,5]tetrazineimmune activationimmune responselatent tuberculosisline probe assayliposomesM. tuberculosismacrophageMDR-TBmicroRNAMmpS5-MmpL5Mtbmurine infection modelMycobacteriumMycobacterium aviumMycobacterium smegmatisMycobacterium tuberculosisomics analysispre-XDR-TBrelapsesecond-line drugsstem cell nichesubtractive genomicssystem analysisTB treatmenttreatment responsetuberculosisuncharacterized proteinsunique metabolic pathwaysVirulenceXDR-TBBiology, life sciencesResearch & information: generalResearch and information: generalFerraris Davide Mariaedt1296151Miggiano RiccardoedtRizzi MenicoedtFerraris Davide MariaothMiggiano RiccardoothRizzi MenicoothBOOK9910557291103321Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment3023812UNINA